skip to main content
Idioma:
Refinado por: Nome da Publicação: Blood remover assunto: Immunology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Brown, Jennifer R. ; Hillmen, Peter ; O’Brien, Susan ; Barrientos, Jaqueline C. ; Reddy, Nishitha ; Coutre, Steven ; Tam, Constantine ; Mulligan, Stephen ; Jaeger, Ulrich ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Cymbalista, Florence ; Thornton, Patrick ; Caligaris-Cappio, Federico ; Delgado, Julio ; Montillo, Marco ; DeVos, Sven ; Moreno, Carol ; Pagel, John ; Burger, Jan A. ; Chung, Devon ; Lin, Jennifer ; Gau, Linda ; Chang, Betty ; McGreivy, Jesse ; James, Danelle F. ; Byrd, John C.

Blood, 2014-12, Vol.124 (21), p.3331-3331 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.